Toward Alzheimer Therapies Based on Genetic Knowledge
- 1 February 2004
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 55 (1) , 15-25
- https://doi.org/10.1146/annurev.med.55.091902.103607
Abstract
Genetic analysis has allowed the dissection of the pathogenic pathway that leads to Alzheimer's disease. It has also been integral to the development of earlier and more accurate diagnostic practices. This analysis has identified many potential therapeutic targets, and clinical trials aimed at these targets are now under way. If these approaches are successful, it will be a spectacular validation of genetic-knowledge–based treatment strategies; if they are not, researchers will need to re-evaluate this approach toward understanding and developing strategies for treating complex diseases.Keywords
This publication has 62 references indexed in Scilit:
- Hints of a Therapeutic Vaccine for Alzheimer's?Neuron, 2003
- Assessing the onset of structural change in familial Alzheimer's diseaseAnnals of Neurology, 2002
- Dopamine miracle: From brain homogenate to dopamine replacementMovement Disorders, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MicePublished by Elsevier ,2001
- CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative DisordersScience, 2000
- Molecular mapping of alzheimer‐type dementia in Down's syndromeAnnals of Neurology, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Rapid induction of Alzheimer A beta amyloid formation by zincScience, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993